PRQR Stock Discussion
ProQR Therapeutics B.V. Description
ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Therapeutic Gene Modulation Genetic Disorder Treatment Of Cystic Fibrosis
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Popular Now
Featured Articles